The substance is composed of (a) 50 mg to 800 mg 1-cycloacrylonitrile-7 - ([S, S] - 2, 8-diazabiciclo [4.3.0] non-8-il) - 6-flu-1, 4-dihydro-8-methoxi-4-oxo-3-quinoncarboxicol (moxifloxacina) or salts (hydrouro),Or a hydrate; (b) at least one dry adhesive; (c) at least one separation additive, such as croscaremosa soda; (d) at least one lubricant, such as magnesium stearate; characterized in that the prepared lactose contains 2.5% to 25% lactose; proposed as a compressor, wherein the prepared lactose core is used. It also refers to a preparation procedure characterized by particles in the water medium moxifloxacin, at least one dry adhesive and lactose; particles are mixed into one adhesive and at least one lubricant,Then the news, then laga This preparation may be an effective way to treat bacterial diseases.
展开▼
